Yoshino, M., Yoshino, J., Smith, G. I., Stein, R. I., Bittel, A. J., Bittel, D. C., … Klein, S. (2022). Worksite-based intensive lifestyle therapy has profound cardiometabolic benefits in people with obesity and type 2 diabetes. Cell Metabolism, 34(10), 1431-1441.e5. https://doi.org/10.1016/j.cmet.2022.08.012

Yoshino, Mihoko, Jun Yoshino, Gordon I. Smith, Richard I. Stein, Adam J. Bittel, Daniel C. Bittel, Dominic N. Reeds, et al. “Worksite-based intensive lifestyle therapy has profound cardiometabolic benefits in people with obesity and type 2 diabetes.” Cell Metabolism 34, no. 10 (October 2022): 1431-1441.e5. https://doi.org/10.1016/j.cmet.2022.08.012.

Yoshino M, Yoshino J, Smith GI, Stein RI, Bittel AJ, Bittel DC, et al. Worksite-based intensive lifestyle therapy has profound cardiometabolic benefits in people with obesity and type 2 diabetes. Cell Metabolism. 2022 Oct;34(10):1431-1441.e5.

Yoshino, Mihoko, et al. “Worksite-based intensive lifestyle therapy has profound cardiometabolic benefits in people with obesity and type 2 diabetes.” Cell Metabolism, vol. 34, no. 10, Elsevier BV, Oct. 2022, pp. 1431-1441.e5. Crossref, doi:10.1016/j.cmet.2022.08.012.

Yoshino M, Yoshino J, Smith GI, Stein RI, Bittel AJ, Bittel DC, Reeds DN, Sinacore DR, Cade WT, Patterson BW, Cho K, Patti GJ, Mittendorfer B, Klein S. Worksite-based intensive lifestyle therapy has profound cardiometabolic benefits in people with obesity and type 2 diabetes. Cell Metabolism. Elsevier BV; 2022 Oct;34(10):1431-1441.e5.